Detalles de la búsqueda
1.
Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma.
J Steroid Biochem Mol Biol
; 100(1-3): 67-78, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16753295
2.
4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
Clin Cancer Res
; 11(6): 2345-54, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15788686
3.
Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
J Steroid Biochem Mol Biol
; 94(1-3): 71-81, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15862952
4.
Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma.
J Steroid Biochem Mol Biol
; 94(1-3): 111-21, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15862956
5.
Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Mol Endocrinol
; 17(10): 2013-27, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12855746
6.
The selective estrogen receptor modulator 4-hydroxy tamoxifen induces G1 arrest and apoptosis of multiple myeloma cell lines.
Ann N Y Acad Sci
; 1010: 321-5, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15033743
Resultados
1 -
6
de 6
1
Próxima >
>>